Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · IEX Real-Time Price · USD

2.420

-0.090 (-3.59%)

At close: Jul 19, 2024, 4:00 PM

2.450

+0.030 (1.24%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Galectin Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2000
Net Income	-44.65	-44.81	-38.87	-30.7	-23.6	-20.18	Upgrade
Depreciation & Amortization	0.01	0.03	0.03	0.04	0.04	0.04	Upgrade
Share-Based Compensation	2.2	2.26	2.87	2.08	1.8	1.68	Upgrade
Other Operating Activities	8.16	9.43	4.82	4.1	1.03	0.73	Upgrade
Operating Cash Flow	-34.28	-32.97	-31.06	-24.31	-20.6	-10.85	Upgrade
Share Issuance / Repurchase	10.03	10.03	0	6.81	0.26	50.47	Upgrade
Debt Issued / Paid	30	30	10	30	0	0	Upgrade
Other Financing Activities	-	-	-	-	-	-0.39	Upgrade
Financing Cash Flow	40.03	40.03	10	36.81	0.26	50.08	Upgrade
Net Cash Flow	5.76	7.07	-21.06	12.51	-20.34	39.23	Upgrade
Free Cash Flow	-34.28	-32.97	-31.06	-24.31	-20.6	-10.85	Upgrade
Free Cash Flow Per Share	-0.55	-0.55	-0.52	-0.41	-0.36	-0.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).